Updates

Zotefoams - New contract worth possibly 10% to sales

July 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The shares have surged ahead since I made them a main buy in the May issue. Not only has the market breathed a sigh of relief that there has been no discounted placing but the company has said it maintained operational continuity throughout April and May, despite challenging conditions. Demand was obviously challenging in April and May but Zotefoams was able to take action to manage costs and seek new business opportunities. It has announced that its Plastazote polyolefin foam has been specified into a substantial UK Government PPE contract - it could be worth c.10% of turnover. This will significantly supplement existing AZOTE volumes and with increasing volume of HPP foam (ZoomX foam) to Nike, which has plans to launch several new prod ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

CML Microsystems

Anexo - Raises money to target VW emissions cases

Zotefoams (April 2023)

Zotefoams (April 2022)

Zotefoams - Big capex plans come to an end (September 2021)

Zotefoams (March 2021)

Zotefoams (September 2020)

Zotefoams - New capacity eases bottleneck (May 2020)

Zotefoams (February 2018)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X